TechFirstCry tightens Q3 loss by 69.5%, profits up 14.3% by The Tamesis Consisting of various other incomes, FirstCry’s overall profits for the quarter got to 22.158 crore (USD 252.49 million). Post Views: 71 Share this Facebook X Telegram Whatsapp Email TagsFirstCrylossnarrowsrevenueRelated Posts After Sudden Loss, Park Avenue Armory Hires New Artistic Leader January 13, 2026 Bonhams Saw Significant Revenue Drop in 2024, In Line With the Big Three January 8, 2026 Meta Endures Billions in Chinese Rip-off and Scams Advertisement Income December 16, 2025 The TamesisLeave a Reply Cancel replyYour email address will not be published. Save my name, email, and website in this browser for the next time I comment. Previous Story50 increasing start-ups in Israel Next StoryBusiness web browser start-up strikes $4.5 b assessment in financing Latest from Blog Indonesia joins US President Trump’s Board of Peace despite domestic unease by The Tamesis The MRI uses AI-powered imaging and Zero Helium technology. by The Tamesis 10 Best Supplements for Gut Health, According to Dietitians by The Tamesis ‘Cellness’, Bold Makeup and ’80s Hair: The 2026 Beauty Trends Brands Need to Know by The Tamesis Nepali parties ramp up social media spending ahead of elections by The Tamesis The discovery addresses resistance amongst patients after one to two years of treatment. by The Tamesis Indonesia’s House postpones plan to scrap direct regional elections by The Tamesis Museum Nixed Nan Goldin Acquisition Because of Comments on Gaza by The Tamesis Harry Styles’s Disco Routine Includes Eye Patches by The Tamesis Peninsula University Hospital completes full patient relocation by The TamesisRelated Posts After Sudden Loss, Park Avenue Armory Hires New Artistic Leader January 13, 2026 Bonhams Saw Significant Revenue Drop in 2024, In Line With the Big Three January 8, 2026 Meta Endures Billions in Chinese Rip-off and Scams Advertisement Income December 16, 2025 Previous Story50 increasing start-ups in Israel Next StoryBusiness web browser start-up strikes $4.5 b assessment in financing
The discovery addresses resistance amongst patients after one to two years of treatment. by The Tamesis